AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Total Debt

Short-term and long-term borrowings combined.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Total Debt · Q3 FY2025 · quarter ended Sep 2025

Total debt of €1.33M in Q3 FY2025

Q3 FY2025 total debt was €1.33M.

Context

  • Total debt amounted to 0.8% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€1.33M— QoQ
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Debt history

Currency unavailable · from the balance sheet

No Total Debt data reported for this period type.

Total Debt vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Total debt amounts to 0.8% of total assets for AGMB, versus a peer median of 3.8%.
AGMB Competitors
Total Debt for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ANABAnaptysBio, Inc.Mar 2026$277.36M USD+1680.8%-10.1%84.1%
ALMSAlumis Inc. Common StockJun 2026$36.43M USD-6.1%+174.8%6.5%
ACRSAclaris Therapeutics, Inc.Mar 2026$1.99M USD-20.1%+45.7%1.0%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€1.33M EUR——0.8%
EQEquillium, Inc.Mar 2026$692K USD+134.6%-58.7%1.1%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —+64.3%+17.8%3.8%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.